A common medication may have an unexpected effect on a serious eye condition, new research suggests.
Continuous glucose monitoring (CGM) is associated with reduced risk of diabetic retinopathy and proliferative diabetic retinopathy in type 1 diabetes patients. Language barriers and limited health ...
Please provide your email address to receive an email when new articles are posted on . November is Diabetes-related Eye Disease Awareness Month, and early detection and treatment of diabetes are key ...
With the number of diabetes cases surging across India, doctors warn that a silent epidemic of diabetes-related vision loss is emerging, particularly among younger adults. Lack of awareness, delayed ...
Please provide your email address to receive an email when new articles are posted on . Adults taking oral fenofibrate had a 27% reduction in diabetic eye disease progression over 4 years. Fenofibrate ...
CHICAGO — A post-market study of the retina drug faricimab that enrolled only minority populations historically underrepresented in drug clinical trials found Hispanic and Latino patients had worse ...
While eye drops may help alleviate some symptoms of diabetic retinopathy, they don’t target the underlying blood vessel damage in your retina. Retinopathy is a possible complication of diabetes. At ...
Researchers have developed the world's first real-world head-to-head testing platform to determine whether commercial artificial intelligence (AI) algorithms are fit for NHS use to detect disease in a ...
Glucagon-like peptide 1 receptor agonists (GLP-1 RAs) and fenofibrates are associated with a reduced risk for diabetic macular edema (DME) in patients with type 2 diabetes, while calcium channel ...
Diabetic eye disease is a leading cause of vision loss in individuals aged 20 to 74,(3) and diabetic macular edema (DME), left untreated, is the leading cause of blindness in diabetic patients. The ...
NEW HAVEN, Conn. (WTNH) — In Monday’s Health Headlines, November is Diabetic Eye Disease Awareness Month. What is diabetic eye disease? How early can it start after a diabetes diagnosis, and what ...
A novel AI-powered retina tracker can analyze retinal images with near-perfect accuracy in under one second, according to a study presented Monday at ENDO 2025, the Endocrine Society's annual meeting ...